Page last updated: 2024-09-05

technetium tc 99m pentetate and Budd-Chiari Syndrome

technetium tc 99m pentetate has been researched along with Budd-Chiari Syndrome in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ichihara, T; Kitano, T; Maeda, H; Matsumura, K; Nakatsuka, A; Takase, K; Takashiba, Y; Takeda, K; Yamakado, K1

Other Studies

1 other study(ies) available for technetium tc 99m pentetate and Budd-Chiari Syndrome

ArticleYear
Binding rate constant of Tc-99m DTPA galactosyl human serum albumin measured by quantitative dynamic SPECT--clinical evaluation as a total and regional liver function test.
    Annals of nuclear medicine, 2001, Volume: 15, Issue:3

    Topics: Adult; Aged; Budd-Chiari Syndrome; Chronic Disease; Female; Humans; Liver; Liver Diseases; Liver Function Tests; Male; Middle Aged; Radiopharmaceuticals; Reference Values; Regression Analysis; Severity of Illness Index; Technetium Tc 99m Aggregated Albumin; Technetium Tc 99m Pentetate; Tomography, Emission-Computed, Single-Photon

2001